Industry powerhouse to fuel business growth strategy

NEW YORK, Dec. 12, 2024 /PRNewswire/ — Glia, the leader in customer interaction technology, today announced that collaboration, contact center industry leader Michael Tessler has joined its board of directors to support and help guide the company’s strategic growth plan. 

Tessler brings over 20 years of proven success in growing and scaling technology businesses across the world. He is the co-founder and former CEO of BroadSoft where he led the company to become the global market leader in cloud communications. Under his leadership, the organization grew to over 2,000 employees, serving customers in over 80 countries. By prioritizing the needs of service provider partners and their end customers, Tessler positioned BroadSoft as the preferred cloud provider for the largest and most successful service providers worldwide – ultimately leading to the company’s acquisition by Cisco in 2018. Tessler is currently co-founder and managing partner at True North Advisory, a firm that helps scale customer experience-oriented businesses.

“When I first learned about Glia’s platform and innovation strategy, I knew it was different, and I wanted to be a part of it. The company is disrupting contact center tech, offering a much easier, efficient, and modern way of serving customers digitally and over the phone,” said Tessler. “I’m energized to jump in and provide guidance, connections, and whatever I can to help Glia redefine customer interactions in the AI era.”

“We are delighted to welcome Mike to the Glia team,” said Dan Michaeli, CEO and co-founder of Glia. “With decades of proven success guiding companies through all stages, he brings invaluable perspective and expertise to our board. He deeply understands this market and our buyers; we’re looking forward to working together on our next phase of growth.”

About Glia

Glia is the leader and pioneer of Unified Interaction Management—redefining how companies interact with their customers. The Glia Interaction Platform unifies voice, digital customer service, and AI with a unique ChannelLess® architecture that eliminates data silos, dropped context, and frustration for customers and representatives. With Glia, companies can easily shift volume between channels, and customer connections can evolve naturally. Glia helps its customers harness the power of customer interactions to drive efficiency, loyalty, and revenue.

Glia has partnered with over 500 insurance companies, banks, credit unions, and other financial institutions worldwide to improve the customer experience and drive business results. Named a Deloitte Technology Fast 500™ company for a fifth year in a row and a Great Place to Work (with a 97% employee satisfaction rating), the company has raised over $150 million in funding from top investors and was recently valued at over $1 Billion. Learn more at glia.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/contact-center-technology-pioneer-michael-tessler-joins-glias-board-of-directors-302329713.html

SOURCE Glia

MELVILLE, N.Y., Dec. 12, 2024 /PRNewswire/ — SupplyHouse.com, a leading online supplier of plumbing, HVAC, and electrical supplies, is pleased to announce the relocation of one of its fulfillment centers from Cranbury, New Jersey, to Dayton, New Jersey. The new fulfillment center, located at 30 Apple Orchard Dr., Suite 1, Dayton, NJ 08810, will offer significantly more inventory capacity, a streamlined setup, and faster service for customers in New Jersey and across the Northeast.

The expansion from 200,000 square feet of storage space in SupplyHouse.com’s current Cranbury location to 337,105 square feet in their new Dayton location marks a major milestone for the company during a period of rapid growth.

One of the clearest benefits of the additional space will be a more extensive inventory in terms of both quantity and variety. Beyond increasing the company’s physical capacity, the new facility will boost its operational capabilities as well. The expanded fulfilment center will mean larger staging and packing areas, reduced congestion, and faster order processing to meet rising customer demand, positioning SupplyHouse.com to continue to scale effectively in the future.

“We’re really excited to make this move to Dayton,” said Nando Cunha, Chief Operating Officer at SupplyHouse.com. “We’ll have about double the space, which is a huge win, because we’ll be able to get orders out to customers faster, and it’ll be a great place to work for our fulfillment center team.”

SupplyHouse.com’s other fulfillment centers across the country will remain fully operational for continuing fast and reliable service coast to coast. The company is proud to grow its footprint in New Jersey and looks forward to maintaining a strong presence in the local community.

About SupplyHouse.com:
Headquartered in Melville, NY, SupplyHouse.com is a rapidly growing e-commerce company with four fulfillment center locations across the United States to facilitate fast shipping. Relying on their core values of generosity, respect, innovation, and teamwork (or GRIT), SupplyHouse.com aims to foster a dynamic and tightly knit culture where new ideas are listened to and appreciated.

View original content to download multimedia:https://www.prnewswire.com/news-releases/supplyhouse-expands-to-larger-fulfillment-center-in-new-jersey-302319650.html

SOURCE SupplyHouse.com

BERKELEY HEIGHTS, N.J., Dec. 12, 2024 /PRNewswire/ — Axtria Inc., a global cloud software and data analytics company for the life sciences industry, is proud to announce its position as the leader in Frost & Sullivan’s inaugural Pharmaceutical Commercialization Solutions and Services Industry Radar Report. This recognition highlights Axtria’s unmatched innovation and growth in the pharmaceutical commercialization domain.

“Axtria’s relentless focus on innovation and sustainable growth continues to set it apart as a leading commercial solutions and services provider. By leveraging advanced data science and cloud-based analytics platforms, Axtria is empowering pharmaceutical companies to optimize commercialization operations and enhance patient outcomes globally,” said Aarti Chitale, Frost & Sullivan.

According to Frost & Sullivan, Axtria leads in this report, which measures companies using two key indices:

Growth Index (GI): A company’s performance and ability to execute a robust growth strategy.Innovation Index (II): The development of globally relevant, customer-aligned solutions addressing disruptive megatrends.

“At Axtria, our mission is to become the most admired data analytics company, empowering the global life sciences industry to achieve unprecedented levels of efficiency and effectiveness. We are proud to be recognized as a leader in Frost & Sullivan’s inaugural Pharmaceutical Commercial Solutions and Services Industry Radar Report. This acknowledgment underscores our commitment to innovation, harnessing technologies like AI to fuel advancements that transform operations, enable smarter decisions, and enhance patient outcomes, ultimately shaping the future of healthcare,” said Jassi Chadha, President and CEO of Axtria.

Key Report Highlights Include:

Innovation Excellence – Axtria’s innovative leveraging of data science and cloud-based analytics platforms empowers life sciences companies to enhance patient outcomes. Its suite of platforms—including Axtria DataMAx, Axtria InsightsMAx, Axtria SalesIQ, Axtria CustomerIQ, and Axtria MarketingIQ—streamlines data utilization, enabling pharmaceutical companies to optimize sales, marketing, and end-to-end commercial operations.

Sustainable Growth Leadership – With operations in more than 70 countries and a team of over 3,800 professionals, Axtria achieves annual double-digit growth. Recent expansions include:

New Global Innovation Centers: Recently, Axtria expanded its headquarters in New Jersey and inaugurated its 10th center in Hyderabad, India.Expanding Workforce: Axtria plans to grow its employee base by over 1,000, focusing on roles in data science, software development, and data engineering.Global Footprint: Recent expansions underscore Axtria’s commitment to scaling operations and supporting global healthcare innovation.

Recognition and Strategic Initiatives – Axtria’s focus on thought leadership and knowledge sharing continues to strengthen its brand recall. In June 2024, the company hosted over 350 senior leaders from 65 top pharmaceutical organizations at Axtria Ignite, where they discussed key industry topics such as patient engagement, generative AI, and omnichannel orchestration. This strategic focus positions Axtria as a pioneer in transforming pharmaceutical commercialization operations through technology.

Axtria provides complimentary access to the full report, which can be found here.

About Axtria’s Products and Solutions
Axtria is proud to work with 16 of the top 20 life sciences companies, globally. From our roots as a trusted consultant to our status as one of the world’s leading providers of cloud-based pharmaceutical management software, Axtria powers digital transformations in life sciences. Our experts call upon years of domain experience in the industry to guide pharma giants from brand launches to retirement. Our products go even further. Axtria InsightsMAx™ helps everyone from the C-suite to junior associates uncover trends to make better decisions. Axtria SalesIQ™ helps optimize field forces and provider engagements. Axtria CustomerIQ™ leverages AI-enabled next-best-action omnichannel choices. Axtria MarketingIQ™ turns investment analyses into pinpoint strategies. And Axtria DataMAx™ and DataMAx™ for Emerging Pharma is the data management framework that pulls it all together with best-in-class security and integration.

About Axtria
Axtria helps life sciences companies harness the potential of data science and software to improve patient outcomes by connecting the right therapies to the right patients at the right time. The company is a leading global provider of award-winning cloud software and data analytics to the life sciences industry. We’re proud to deliver proven solutions that help pharmaceutical, medical device, and diagnostics companies complete their journey from data to insights to action, enabling them to earn superior returns on their investments. As a participant in the United Nations Global Compact, Axtria is committed to aligning strategies and operations with universal principles on human rights, labor, environment, and anti-corruption, and taking actions that advance societal goals. For more information, please visit www.axtria.com.

Logo – https://mma.prnewswire.com/media/2256316/Axtria_transparent_bg_Logo.jpg

View original content:https://www.prnewswire.com/in/news-releases/axtria-leads-frost–sullivans-first-pharmaceutical-commercialization-solutions-and-services-industry-radar-report-302329767.html